Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Michaels claims Google-powered AI assistant doubles conversion rate of traditional search
Michaels shared early results of its new Google Gemini-powered AI assistant.
Mythbusters: AI visibility’s biggest misconceptions
AI visibility is evolving quickly, but many of the industry’s biggest assumptions don’t hold up. Experts debunk the biggest myths.
How AI costs are quietly reshaping principal media deals
AI doesn’t have a price. Principal media is absorbing it anyway.